[
  {
    "ts": null,
    "headline": "What To Expect From Gilead In Q3 2025",
    "summary": "Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting. Check out why GILD stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=b5f5ee55f87366db308381563df757bde2335123cbe5c6ab532f82054c10ff85",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761303403,
      "headline": "What To Expect From Gilead In Q3 2025",
      "id": 137202475,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/728909377/image_728909377.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting. Check out why GILD stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=b5f5ee55f87366db308381563df757bde2335123cbe5c6ab532f82054c10ff85"
    }
  }
]